Business Standard

Monday, December 23, 2024 | 05:00 PM ISTEN Hindi

Notification Icon
userprofile IconSearch

GlaxoSmithKline plans sale of $3.7-billion stake in Hindustan Unilever

The firm may offload part or all of its 5.7% holding in HUL through a series of block trades

GlaxoSmithKline, gsk
Premium

The drug maker received the stake, valued at $3.7 billion as of Wednesday, as part of the payment for the sale of a portfolio of assets that was completed this month.

Bloomberg
GlaxoSmithKline is preparing to start a sale of its $3.7 billion stake in Unilever’s listed India unit, according to people familiar with the matter.
 
Glaxo plans to offload part or all of its 5.7% holding in Hindustan Unilever (HUL) through a series of block trades, which could start as soon as the next few days, according to the people.
 
The firm is in discussions with advisors on when to launch the transactions, the people said, asking not to be identified because the information is private.

The

What you get on BS Premium?

  • Unlock 30+ premium stories daily hand-picked by our editors, across devices on browser and app.
  • Pick your 5 favourite companies, get a daily email with all news updates on them.
  • Full access to our intuitive epaper - clip, save, share articles from any device; newspaper archives from 2006.
  • Preferential invites to Business Standard events.
  • Curated newsletters on markets, personal finance, policy & politics, start-ups, technology, and more.
VIEW ALL FAQs

Need More Information - write to us at assist@bsmail.in